Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
05/2011
05/17/2011US7942916 Phototreatment device for use with coolants and topical substances
05/17/2011US7942915 Phototreatment device for use with coolants
05/17/2011CA2474242C Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
05/12/2011WO2011056382A1 Angiogenesis promoted by caged growth factors
05/12/2011WO2011055047A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding
05/12/2011US20110112464 Meso-substituted porphyrins
05/11/2011EP2318052A1 Nanocrystal nano-emulsion
05/11/2011EP2317857A1 Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth
05/11/2011EP2072584B1 Phthalocyanine dyes, their preparation and use
05/11/2011EP1372786B1 Cytoprotection by phosphotyrosine
05/11/2011CN102056629A A photosensitising composition and its uses
05/11/2011CN102056628A Inorganic nanoparticles, preparation and uses thereof
05/05/2011WO2011051406A1 Sterilization of biodegradable hydrogels
05/05/2011CA2776723A1 Sterilization of biodegradable hydrogels
05/04/2011CN1842322B Non-polar photosensitizer formulations for photodynamic therapy
05/04/2011CN102046632A Azo and diaza derivatives and uses thereof in phototherapy
05/04/2011CN101703535B Method for improving content of drug efficacy components of ginkgo leaf
05/04/2011CN101155782B Potentiator for radiation therapy comprising pyridine derivative as active ingredient
05/03/2011US7935332 Presbyopia treatment by lens alteration
04/2011
04/28/2011US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease
04/27/2011CN102036684A RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
04/27/2011CN102030765A Ether-linked porphyrin dimer salt and preparation method thereof
04/26/2011US7931640 Method for muscle delivery of drugs, nucleic acids and other compounds
04/26/2011CA2388656C Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma
04/26/2011CA2353554C Palladium-substituted bacteriochlorophyll derivatives and use thereof
04/21/2011WO2011045029A1 A composite comprising at least one type of perfluoroalkyl-perfluoro-phthalocyanine
04/21/2011WO2011044671A1 Porphyrin nanovesicles
04/21/2011WO2010067199A3 Mixtures of plants in spagyric mother tincture for dry cough in babies
04/21/2011CA2776796A1 Porphyrin nanovesicles
04/20/2011EP1224461B1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
04/19/2011US7928097 Photoreactive compounds and compositions
04/19/2011CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
04/14/2011WO2011044589A2 Photokinetic ocular drug delivery methods and apparatus
04/14/2011US20110086915 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
04/13/2011EP2308508A1 Photodynamic therapy using chemoluminescence and a ligand-photosensitiser conjugate
04/13/2011EP2307001A1 Control of blood vessel physiology to treat skin disorders
04/12/2011CA2185644C Use of green porphyrins in ocular diagnosis and therapy
04/07/2011WO2011020097A3 Ultrasonic surgical apparatus and silicon waveguide and methods for use thereof
04/07/2011US20110082448 Pharmaceutical Compositions
04/06/2011EP2303924A2 Lm-antibodies, functional fragments, lm-1 target antigen, and methods for making and using same
04/06/2011EP2303326A2 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps)
04/06/2011CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses
04/05/2011CA2330916C Triterpene compositions and methods for use thereof
03/2011
03/31/2011WO2010093528A3 On-demand and reversible drug release by external cue
03/30/2011EP2301570A1 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins
03/30/2011EP2300067A2 Drug delivery composition
03/30/2011EP2300054A2 Inorganic nanoparticles of high density to destroy cells in-vivo
03/29/2011US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
03/29/2011US7914509 Ultrasound catheter
03/29/2011CA2452845C Dye-sulfenates for dual phototherapy
03/29/2011CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof
03/24/2011WO2011033084A1 Substrates comprising switchable ferromagnetic nanoparticles
03/23/2011EP2298327A1 Anti-tumor agent
03/23/2011EP2296706A2 Photochemical internalisation of kinase inhibitors
03/23/2011EP2296681A2 A homeopathic formulation
03/23/2011EP2296678A1 Modulating interstitial pressure and oncolytic viral delivery and distribution
03/22/2011CA2379357C Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
03/17/2011WO2011031955A2 Optical monitoring of leukemia
03/17/2011WO2011029170A1 Process to obtain a homeopathic medicament and use thereof
03/15/2011US7906515 Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation
03/15/2011US7906102 Ligands to radiation-induced molecules
03/10/2011WO2011026572A1 Dispersant stabilization of inorganic non-metallic particles
03/10/2011US20110060270 Microporation of Tissue for Delivery Of Bioactive Agents
03/09/2011EP2291325A2 Methods for controlling heat generation of magnetic nanoparticles and heat generating nanomaterials
03/08/2011US7901673 Blood transfusion
03/03/2011WO2011023769A1 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
03/03/2011WO2010028216A8 Porphyrazine optical and dual optical/mr contrast and therapeutic agents
03/03/2011US20110053240 Dna damaging agents in combination with tyrosine kinase inhibitors
03/02/2011EP2289553A1 Dispersant stabilization of inorganic non-metallic particles
03/02/2011EP2288350A1 Method of treatment with potentised stereoisomer of glutamate
02/2011
02/23/2011EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
02/23/2011EP2287205A2 Photoreactive polysaccharide. photocrosslinked polysaccharide products, the method of making them and medical materials made therefrom
02/23/2011EP2286868A2 Apparatus for microporation of biological membranes using thin film tissue interface devices, and method for manufacturing
02/23/2011EP2285882A1 Polymer microgel beads
02/23/2011EP2285881A1 Polymer microgel beads and preparative method thereof
02/22/2011US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system
02/17/2011WO2011020097A2 Ultrasonic surgical apparatus and silicon waveguide and methods for use thereof
02/17/2011WO2011018636A2 Photochemical internalization method
02/17/2011WO2011018635A2 Photosensitizing compositions
02/17/2011WO2011018624A1 Ultrasound couplant
02/17/2011CA2771022A1 Photochemical internalization method
02/17/2011CA2771021A1 Photosensitizing compositions
02/17/2011CA2770743A1 Ultrasonic surgical apparatus and silicon waveguide and methods for use thereof
02/16/2011EP2283872A2 Non-covalent bioconjugates useful for diagnosis and therapy
02/16/2011EP2283863A1 Model and method for angiogenesis inhibition
02/16/2011EP2282781A1 Methods for radiolabelling synthetic polymers
02/16/2011EP2282775A2 Vector for use in medicine
02/16/2011CN101977634A Method for the synthesis of hollow spheres
02/16/2011CN101972478A 抗体治疗 Antibody therapy
02/15/2011CA2408332C Supports for photosensitizer formulations
02/10/2011US20110034753 Stem cell targeting and activation using magnetic particles
02/09/2011EP1459738B1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties
02/02/2011EP1951303B1 Therapy with anti-cd4 antibodies and radiation
02/01/2011US7878203 Phototherapeutic treatment method using a passive host medium containing nanoparticles
01/2011
01/27/2011US20110021603 TRPM-2 Antisense Therapy
01/27/2011US20110021528 Novel hydroxamates as therapeutic agents
01/26/2011EP2277545A1 Particle with inducible shape alteration
01/26/2011EP2277544A1 Biocompatible magnetic nano-clusters containing iron oxide respectively iron oxide - boron with primary use in magnetic drug targeting and boron neutron capture therapy
01/26/2011CN101953795A Drug delivery nanodevice, its preparation method and uses thereof
01/25/2011CA2457856C Sulphonated meso-tetraphenyl chlorins and their use as therapeutic agents
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 95